DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Disitamab Vedotin Injection|DRUG: Pertuzumab Injection|DRUG: Toripalimab
Sponsor: RemeGen Co., Ltd.